---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011375"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T17:55:40.487658+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Kala shareholders approve equity plan increase, reject name change at annual meeting

## Summary
- Approved A&R 2017 Equity Incentive Plan; adds 1.25M shares, extends term to June 2033.
- Elected C. Daniel Myers and Howard B. Rosen as Class III directors for three-year terms.
- Advisory vote on executive compensation passed (498,054 for, 57,912 against); frequency set every year.
- Proposal to rename to 'Kala Bio, Inc.' did not receive required votes; 1.15M for vs 11,194 against.

## SEC filing metadata
- accession: 0001558370-23-011375
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/kala-20230622x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011375
- JSON: https://secwatch.observer/filing/0001558370-23-011375.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011375.txt

## Key facts
- Shareholder Votes
  KALA BIO, Inc. shareholders approved Election of C. Daniel Myers and Howard B. Rosen as Class III directors.
  - Proposal: director election
  - Outcome: passed
  source text: The results of the stockholders’ vote with respect to the election of such Class III directors were as follows: ​ Votes For Votes Withheld Broker Non- Votes C. Daniel Myers 544,974 26,177 594,432 Howard B. Rosen 550,334 20,817 594,432
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm
- Shareholder Votes
  KALA BIO, Inc. shareholders approved Non-binding advisory vote on frequency of future say-on-pay votes.
  - Proposal: say on pay frequency
  - Outcome: passed
  source text: were as follows: ​ Every One Year Every Two Years Every Three Years Votes Abstaining Broker Non- Votes 546,761 4,425 17,435 2,530 594,432
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm
- Shareholder Votes
  KALA BIO, Inc. shareholders rejected Amendment to Restated Certificate of Incorporation to change company name to Kala Bio, Inc..
  - Proposal: charter amendment
  - Outcome: failed
  source text: were as follows: ​ Votes For Votes Against Votes Abstaining Broker Non- Votes 1,151,465 11,194 2,924 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm
- Shareholder Votes
  KALA BIO, Inc. shareholders approved Approval of Amended and Restated 2017 Stock Option and Incentive Plan.
  - Proposal: equity plan
  - Outcome: passed
  source text: were as follows: ​ Votes For Votes Against Votes Abstaining Broker Non- Votes 495,640 71,992 3,519 594,432
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm
- Shareholder Votes
  KALA BIO, Inc. shareholders approved Non-binding advisory vote on compensation paid to named executive officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: 2. The Company’s stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers. The results
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000155837023011375/0001558370-23-011375-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.